Skip to content

You will find external funding opportunities and opportunities for collaborating with Industry on this page. For internal funding opportunities please see the Concept Development Award pages


Industry Collaboration Opportunities

We maintain a list of collaboration opportunities from our industry contacts below. If any are of interest to you please contact the enterprise team and we can provide some further information


View all Close all


LifeArc Rare disease philanthropic Fund (£5million) (no expiration date)

This fund offers grants for rare disease treatments. The assessment panel meets twice per year and prefers projects with strong scientific rationale and credible IP potential with route-to-patient in mind.

MRC Fund administered by LifeArc to support small-scale studies (no expiration date)

This fund supports small-scale studies, building upon research undertaken in MRC Units and Institutes, to provide proof of concept for translational projects.

LifeArc Seed Fund £25m (no expiration date)

This fund offers 3-4 investments per year of no more than £2 million into nascent or early-stage spin out companies which align with its strategic disease priorities.


Therapies for Rare Genetic Diseases
{Accordion Item Content}


External Funding Opportunities

View all Close all


Lean Launch - Market Discovery

10-week online market discovery programme designed to test out a business idea, new technology, product or service.

Remit: Grant for market discovery activities & business advisor support

Value: £3,500

Eligibility: Early career researchers (from PhD to Post doc) – team must include a PI (Lecturer and above)

Deadline: Multiple

Contact for application:

Biomedical Catalyst Round 1: Indsutry-led R&D

Deadline: Wednesday 25th May, 2022

Funding: Project’s total eligible costs must be between £150,000 and £4 million

Innovate UK will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes. The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility. Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease 
  • the development of digital health technologies

More information

i4i Challenge Awards

Deadline: Thursday 2nd June, 2022

Funding: Discretionary

The Challenge Awards will fund investigations of MedTech innovations in healthcare settings. The lead applicant or one of the co-applicants must be from an NHS Trust or NHS Service Provider. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE-marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment. Please note that nearly CE-marked technologies refers to technologies that are currently under Notified Body assessment, whereby all of the mandatory testing has been completed.

More Information

Surgical MIC Incubator Packages

Deadline:  Friday 29th April, 2022

Funding: Up to £5K per project

This is a seed funding call for the early development of novel technology-based solutions applicable to colorectal, HPB, neuro and/or vascular surgery (including wound care). Applications are invited from academic institutions, NHS Trusts, third sector organisations and industry. Incubator packages are designed to support the development of new medical technologies and they help teams to develop and progress their idea. Incubator packages are suitable for applicants that are looking to conduct the following activities (not limited to these activities) such as feasibility research on a new device/technology; prototype design and development; filing of Intellectual Property, Patents etc.; focus groups and engagement activities (i.e. academic/clinical/industry).

More Information

i4i Product Development Awards

Deadline: Tuesday 10th May, 2022

Funding: Discretionary

i4i Product Development Awards (PDA) support innovations at any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions. This funding stream is researcher-led and does not specify topics for research. Research proposals must include applicants from two organisation types: an NHS Trust, higher education institution or small-to-medium-sized enterprise (SME).

More Information

Developmental Pathway Funding Scheme

Deadline: Wednesday 20th July, 2022

Funding: Total Fund : £30,000,000

Apply for MRC's funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be based at a UK research organisation (includes NHS bodies) eligible for UKRI funding. Project should focus on at least one of the following stages of development:

  • early development and design
  • pre-clinical testing
  • early-phase clinical studies and trials (up to phase 2a).

There’s no limit on the amount of funding you can apply for, typically fund 80% of the full economic cost. This is an ongoing scheme with a budget of approximately £30 million a year. Application rounds open three times a year, in February, June and October.

More Information

i4i FAST (Funding At the Speed of Translation) Pilot Scheme

Deadline: None specified

Funding: Up to £50k per project

The brand new i4i FAST (Funding At the Speed of Translation) funding scheme is inviting innovators to submit applications that will answer a specific question, fund a single piece of activity or fill a specific evidence gap across all technology readiness levels. This could provide pivotal support by allowing innovations to be de-risked, further explored to justify further research and investment or to fail fast if simply not viable. Research themes can address any area of existing or emerging clinical unmet need.

This is the first round of i4i FAST Awards and will initially run as a pilot scheme. The Awards provide between £15k to £50k of funding for projects that can last between 3 to 6 months. FAST Awards are designed to have a rapid turnaround, and decisions to fund will be made within 6 to 8 weeks.

i4i FAST is a rolling call and there is no submission deadline. Applications can be submitted from 13:00 on 04 April 2022. The call can close at any time subject to budget and evaluation requirements.

More Information

Global Innovation Fund

Deadline: None specified

Funding: Discretionary

The Global Innovation Fund is a non profit innovation fund headquartered in London with an office in Washington D.C. that invests in the development, rigorous testing, and scaling of innovations targeted at improving the lives of the world's poorest people. Through our grants and risk capital, we help breakthrough solutions to global development challenges from for profit firms, non profit organisations, researchers, and government agencies to maximise their impact and affect meaningful change.

More Information

Nesta Impact Investment

Deadline: None specified

Funding: Funding: £1,000,000

Nesta Impact Investments is a £17.6m fund investing in life changing innovations that help tackle the major challenges faced by older people, children and communities in the UK.

More Information



Find a profileSearch by A-Z